Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.
about
Adjuvant radiotherapy for stage I endometrial cancerAdjuvant radiotherapy for stage I endometrial cancerReview of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task forceMembrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumorsReceipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study.Prospective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancerMajor clinical research advances in gynecologic cancer in 2010The effect of lymphadenectomy and radiotherapy on recurrence and survival in endometrial carcinoma. Experience in a population reference centreRisk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria.Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy.Intensity Modulated Radiotherapy (IMRT) in the postoperative treatment of an adenocarcinoma of the endometrium complicated by a pelvic kidneyControversies in the adjuvant therapy of endometrial cancerPostoperative Radiotherapy Alone Versus Chemoradiotherapy in Stage I-II Endometrial Carcinoma: An Investigational and Propensity Score Matching AnalysisThe role of radiotherapy in endometrial cancer: current evidence and trendsInterobserver agreement for endometrial cancer characteristics evaluated on biopsy material.Critical analysis of cases of endometrial carcinoma of the uterine corpus incidentally diagnosed after incomplete surgery for other indications. Three case reports and a review of the literature.Treatment outcomes and prognostic factors in mexican patients with endometrial carcinoma with emphasis on patients receiving radiotherapy after surgery: an institutional perspective.Controversies in the treatment of early stage endometrial carcinoma.An overview of uterine cancer and its management.Postoperative radiotherapy for endometrial cancerHigh-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapySequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studiesA Retrospective Six Years Analysis of Survival and Late Morbidity of Post-operative Gynaecological Malignancy Treated with External Radiotherapy Followed by Brachytherapy in Medical College & Hospitals, Kolkata.Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis.Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma.The impact of disease progression on perceived health status and quality of life of long-term cancer survivors.Patterns of failure after postoperative radiation therapy for endometrial carcinoma.No cookie-cutter oncology: individualized treatment approaches for women with corpus endometrial cancer.Current therapy of patients with endometrial carcinoma. A critical review.Consensus on treatment of endometrium carcinoma with brachytherapy.Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.Non-closure of peritoneum after abdominal hysterectomy for uterine carcinoma does not increase late intestinal radiation morbidityBladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer.Recurrence and survival in surgically treated endometrioid endometrial cancer.A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study.External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates.Clinical outcomes of image guided radiation therapy (IGRT) with gold fiducial vaginal cuff markers for high-risk endometrial cancer.
P2860
Q24200253-0CDD00EA-833A-4917-A4A6-A044BF9701F0Q24201209-DDC55C81-7A37-4340-9010-643F9319BDB4Q27009163-6C28A182-566F-4DC6-A9FE-932DCDBA8464Q30278773-935CD2CB-D115-46AB-9461-C0E2E2156C9EQ31120922-218CCEA6-F5F3-48D8-879A-EE1AC36A0AFDQ34039320-042DC316-5C8C-47C6-9F7B-A24EA98853C3Q34517694-A8EC2FA1-3958-4809-A10C-E5D40428BF3CQ34719540-2FA88FE5-2312-4A60-8855-AF679C096634Q34996976-4F5596FD-473D-4335-916A-B3883C4D0497Q35024980-FD3FC5BC-EAAB-4A9E-A6CE-8EDCB61460F0Q35165686-3BBEC575-627A-4B7A-8022-E3F95DFFE4EAQ35238303-BBD64104-354F-4666-8B88-7ADA6CE8E81CQ35429722-3B575FF3-FA71-43E8-91AB-30DE72DA1FE4Q35539990-F5B68D6A-B38D-4C46-B121-4808D92D846AQ35837887-84DE4A09-0FD0-4BCE-9FB4-B3DCEF32EBF9Q35903644-0136E9E6-9B1B-4B4D-9BF1-E82207C9C84AQ35996813-A18CCF75-3307-494A-ACA0-17EE483FA724Q36012083-4F35CB18-B33B-4C5F-9558-4BC000434D85Q36352068-C48092EF-EEA0-444B-B38F-80052354E63FQ36395244-AD1089A4-C7B0-46EB-8CE2-F2D339B8EA10Q36551196-CBCF769C-52CD-48E8-9A23-F6F9166C507CQ36554430-A04E2DAA-38E5-4CEF-BB8E-CCC97CB0EDD5Q36877914-6949C9DE-0554-4EF1-B72B-B7A6AFF43A49Q36931011-AF42C0B6-2150-4F82-9BA9-3779C1B3A78CQ37139359-3BEBC508-06F7-4E96-96D1-5E11D0D098E2Q37271636-43AE0E1C-0A42-4514-AB23-421169FFD739Q37341765-AC3B9B8B-87E0-47FD-B1E1-ADDEF966A8DEQ37774355-0163F766-5A1B-46EF-BF3B-108371951FD1Q37970571-40F0230A-E109-4C57-BACF-3BE62E21839CQ38000942-CD093254-DFF8-4EF8-A3CF-37E3D26BB4AFQ38042049-23C13E2C-E5A8-415E-9088-33D01C4C90D1Q38705372-50ED15E8-2A68-464B-BEF8-33776A355AA7Q38853338-FE3EA77B-F003-440A-B3B3-2F05A2C92920Q39036939-A3F63967-D79B-4318-9019-DDAF1AED423EQ41966422-344B4B29-90EB-4B64-A44A-C06EA981F319Q43150854-ECE51478-5DE8-429C-82F3-4050B89408C1Q43986593-A19E9DB5-FC53-4859-882D-F9108A2240D9Q45392106-FA32B618-5114-427A-ABA6-5A8FEF722848Q45732678-2B2129A5-668E-4CD8-A5FA-43B02EBCD2C0Q49078131-77139ADC-3163-41EE-A0B6-948F0BB9FFDA
P2860
Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Postoperative radiotherapy for ...... with central pathology review.
@ast
Postoperative radiotherapy for ...... with central pathology review.
@en
type
label
Postoperative radiotherapy for ...... with central pathology review.
@ast
Postoperative radiotherapy for ...... with central pathology review.
@en
prefLabel
Postoperative radiotherapy for ...... with central pathology review.
@ast
Postoperative radiotherapy for ...... with central pathology review.
@en
P2093
P1476
Postoperative radiotherapy for ...... with central pathology review
@en
P2093
Astrid N Scholten
Carla C Wárlám-Rodenhuis
Henk Beerman
Jan J Jobsen
Karin A J De Winter
Ludy C H W Lutgens
Marnix L M Lybeert
Mat van Lent
PORTEC Study Group
Peter C M Koper
P304
P356
10.1016/J.IJROBP.2005.03.007
P407
P577
2005-05-31T00:00:00Z